Maria J Merino

Maria J Merino

UNVERIFIED PROFILE

Are you Maria J Merino?   Register this Author

Register author
Maria J Merino

Maria J Merino

Publications by authors named "Maria J Merino"

Are you Maria J Merino?   Register this Author

100Publications

4389Reads

15Profile Views

MRI-guided pelvic lymph node biopsy via transrectal approach in prostate cancer.

Urol Case Rep 2020 May 27;30:101129. Epub 2020 Jan 27.

Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eucr.2020.101129DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC7013174PMC
May 2020

Growth Rates of Genetically Defined Renal Tumors: Implications for Active Surveillance and Intervention.

J Clin Oncol 2020 Feb 21:JCO1902263. Epub 2020 Feb 21.

Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1200/JCO.19.02263DOI Listing
February 2020

Adrenocortical carcinoma masquerading as pheochromocytoma: a histopathologic dilemma.

Endocrinol Diabetes Metab Case Rep 2020 Jan 8;2020. Epub 2020 Jan 8.

Pediatric Oncology Branch, Rare Tumor Initiative, Center for Cancer Research, National Cancer Institute, Clinical Center.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1530/EDM-19-0147DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6993251PMC
January 2020

Apical periurethral transition zone lesions: MRI and histology findings.

Abdom Radiol (NY) 2019 Aug 29. Epub 2019 Aug 29.

Molecular Imaging Program, NCI, NIH, 10 Center Drive, Room B3B85, Bethesda, MD, 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00261-019-02194-xDOI Listing
August 2019

A Grading System for the Assessment of Risk of Extraprostatic Extension of Prostate Cancer at Multiparametric MRI.

Radiology 2019 03 22;290(3):709-719. Epub 2019 Jan 22.

From the Department of Urology and Pediatric Urology, University Medical Center, Mainz, Germany (S.M.); Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Md (S.M., J.B., S.G., G.H., K.R., P.A.P.); Molecular Imaging Program, National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Building 10, Room B3B85, Bethesda, MD 20892-1088 (S.M., C.S., M.C., P.L.C., B.T.); Division of Cancer Treatment and Diagnosis: Biometric Research Program, National Cancer Institute, National Institutes of Health, Rockville, Md (J.H.S.); Clinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, NCI Campus at Frederick, Frederick, Md (S.H.); Laboratory of Pathology, National Cancer Institute, National Institutes of Health, Bethesda, Md (M.J.M.); and Center for Interventional Oncology, National Cancer Institute and Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, Md (B.J.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2018181278DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6394788PMC
March 2019

Interreader Variability of Prostate Imaging Reporting and Data System Version 2 in Detecting and Assessing Prostate Cancer Lesions at Prostate MRI.

AJR Am J Roentgenol 2019 Mar 27:1-8. Epub 2019 Mar 27.

14 National Institutes of Health Clinical Center, Imaging Biomarkers and Computer-Aided Diagnosis Laboratory, Radiology and Imaging Sciences, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.18.20536DOI Listing
March 2019

CDC73 Germline Mutation in a Family With Mixed Epithelial and Stromal Tumors.

Urology 2019 02 16;124:91-97. Epub 2018 Nov 16.

Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00904295183120
Publisher Site
http://dx.doi.org/10.1016/j.urology.2018.11.013DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6382532PMC
February 2019

A Multireader Exploratory Evaluation of Individual Pulse Sequence Cancer Detection on Prostate Multiparametric Magnetic Resonance Imaging (MRI).

Acad Radiol 2019 01 25;26(1):5-14. Epub 2018 Apr 25.

Molecular Imaging Program, National Cancer Institute, National Institutes of Health, 10 Center Drive, Room B3B85, Bethesda, MD 20814. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.acra.2018.03.024DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6202287PMC
January 2019

Added Value of Multiparametric Magnetic Resonance Imaging to Clinical Nomograms for Predicting Adverse Pathology in Prostate Cancer.

J Urol 2018 11 29;200(5):1041-1047. Epub 2018 May 29.

Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Center for Interventional Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2018.05.094DOI Listing
November 2018

Germline VHL gene variant in patients with von Hippel-Lindau disease does not predict renal tumor growth.

Abdom Radiol (NY) 2018 10;43(10):2743-2749

Department of Radiology and Imaging Sciences, National Institutes of Health Clinical Center, 10 Center Dr. Bethesda, Bethesda, MD, 20814, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00261-018-1540-1DOI Listing
October 2018

Morphological changes induced by intraprostatic PSA-based vaccine in prostate cancer biopsies (phase I clinical trial).

Hum Pathol 2018 08 30;78:72-78. Epub 2018 Apr 30.

Laboratory of Tumor Immunology and Biology, CCR, NCI, NIH, Bethesda, MD 20892.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.humpath.2018.04.013DOI Listing
August 2018

Validation of PI-RADS Version 2 in Transition Zone Lesions for the Detection of Prostate Cancer.

Radiology 2018 08 22;288(2):485-491. Epub 2018 May 22.

From the Center for Interventional Oncology (J.N.T., H.A.N., P.S., B.J.W.), Molecular Imaging Program (F.V.M., P.L.C., B.T.), Laboratory of Pathology (M.J.M.), and Urologic Oncology Branch (P.A.P.), National Cancer Institute and Clinical Center, National Institutes of Health, 10 Center Dr, Building 10, MSC 1182, Room B3B85, Bethesda, MD 20892; Department of Urology, University of Michigan Health System, Ann Arbor, Mich (A.K.G.); and Department of Surgery, Division of Urology, University of Maryland Medical Center, Baltimore, Md (M.M.S.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2018170425DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6071681PMC
August 2018

Can Apparent Diffusion Coefficient Values Assist PI-RADS Version 2 DWI Scoring? A Correlation Study Using the PI-RADSv2 and International Society of Urological Pathology Systems.

AJR Am J Roentgenol 2018 Jul 7;211(1):W33-W41. Epub 2018 May 7.

1 Molecular Imaging Program, National Cancer Institute, National Institutes of Health, 10 Center Dr, Rm B3B85, Bethesda, MD 20814.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.17.18702DOI Listing
July 2018

CD38 knockout suppresses tumorigenesis in mice and clonogenic growth of human lung cancer cells.

Carcinogenesis 2018 02;39(2):242-251

Department of Microbiology, University of Alabama at Birmingham, Birmingham, AL, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/carcin/bgx137DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5862338PMC
February 2018

The FOXA2 transcription factor is frequently somatically mutated in uterine carcinosarcomas and carcinomas.

Cancer 2018 01 21;124(1):65-73. Epub 2017 Sep 21.

Cancer Genetics and Comparative Genomics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/cncr.30971DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5735010PMC
January 2018

What Are We Missing? False-Negative Cancers at Multiparametric MR Imaging of the Prostate.

Radiology 2018 01 20;286(1):186-195. Epub 2017 Oct 20.

From the Molecular Imaging Program (S.B., S.G., M.B., M.D.G., F.V.M., P.L.C., B.T.), Urologic Oncology Branch (A.K.G.), and Laboratory of Pathology (V.M., M.J.M.), National Cancer Institute, National Institutes of Health, 10 Center Dr, Room B3B85, Bethesda, MD 20892; Department of Radiology, George Washington University Hospital, Washington, DC (S.B., M.T., P.A.P.); and Center for Interventional Oncology, National Cancer Institute, and Department of Radiology and Imaging Sciences, Clinical Center, National Institutes of Health, Bethesda, Md (B.J.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2017152877DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5749595PMC
January 2018

Validation of the Dominant Sequence Paradigm and Role of Dynamic Contrast-enhanced Imaging in PI-RADS Version 2.

Radiology 2017 12 19;285(3):859-869. Epub 2017 Jul 19.

From the Molecular Imaging (M.D.G., F.V.M., P.L.C., B.T.) and Biometric Research (J.H.S.) Programs, Laboratory of Pathology (M.J.M.), and Urologic Oncology Branch (P.A.P.), National Cancer Institute, National Institutes of Health, 10 Center Dr, Room B3B85, Bethesda, MD 20892; Imaging Biomarkers and Computer-Aided Diagnosis Laboratory, Department of Radiology and Imaging Sciences, National Institutes of Health Clinical Center, Bethesda, Md (N.L., R.M.S.); Department of Radiology, University of Cambridge School of Medicine, Cambridge, England (T.B.); Department of Radiology, Universidade Federal Fluminense, Rio de Janeiro, Brazil (L.K.B.); Department of Body Imaging, CDPI Clinics/DASA, Rio de Janeiro, Brazil (L.K.B.); Department of Radiology, George Washington University Hospital, Washington, DC (S.B.); Department of Radiology, Hacettepe University, Ankara, Turkey (I.M.K.); Department of Diagnostic Radiology Singapore General Hospital, Singapore (Y.M.L.); Department of Radiology, Walter Reed National Military Medical Center, Bethesda, Md (J.M.); Department of Radiology, Nephrology Center, Mansoura University, Mansoura, Egypt (H.S.); Center for Interventional Oncology, National Cancer Institute and Clinical Center, and Radiology Imaging Sciences, National Institutes of Health, Bethesda, Md (B.J.W.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2017161316DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5708285PMC
December 2017

Genomic and metabolic characterization of a chromophobe renal cell carcinoma cell line model (UOK276).

Genes Chromosomes Cancer 2017 10 24;56(10):719-729. Epub 2017 Jul 24.

Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.22476DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5561006PMC
October 2017

18F-DCFBC Prostate-Specific Membrane Antigen-Targeted PET/CT Imaging in Localized Prostate Cancer: Correlation With Multiparametric MRI and Histopathology.

Clin Nucl Med 2017 Oct;42(10):735-740

From the *Molecular Imaging Program, National Cancer Institute, Bethesda; †Clinical Research Directorate/Clinical Monitoring Research Program, Leidos Biomedical Research, Inc, Frederick, MD; ‡Institute of Diagnostic Radiology, Department of Medical Area, University of Udine, Udine, Italy; §Office of the Clinical Director/Center for Cancer Research/National Cancer Institute, Bethesda; ∥Applied/Developmental Research Directorate, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick; ¶Office of the Pharmaceutical Quality, FDA/CDER, Silver Spring; **Russell H. Morgan Department of Radiology and Radiological Science, Johns Hopkins Medical Institutions, Baltimore; ††Laboratory of Pathology, National Cancer Institute, Bethesda; ‡‡Division of Cancer Treatment and Diagnosis, National Cancer Institute, Rockville; §§Center for Interventional Oncology, National Cancer Institute and Clinical Center, and Radiology Imaging Sciences, National Institutes of Health, Bethesda; and ∥∥Urologic Oncology Branch, National Cancer Institute, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RLU.0000000000001804DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5703072PMC
October 2017

Prospective Evaluation of PI-RADS™ Version 2 Using the International Society of Urological Pathology Prostate Cancer Grade Group System.

J Urol 2017 09 31;198(3):583-590. Epub 2017 Mar 31.

Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2017.03.131DOI Listing
September 2017

Results of Screening in Familial Non-Medullary Thyroid Cancer.

Thyroid 2017 08 19;27(8):1017-1024. Epub 2017 Jul 19.

2 Endocrine Oncology Branch, National Cancer Institute, National Institutes of Health , Bethesda, Maryland.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1089/thy.2016.0668DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5564020PMC
August 2017

Should Hypoechoic Lesions on Transrectal Ultrasound Be Sampled During Magnetic Resonance Imaging-targeted Prostate Biopsy?

Urology 2017 Jul 15;105:113-117. Epub 2016 Nov 15.

Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD; Laboratory of Pathology, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urology.2016.11.012DOI Listing
July 2017

Multiple Recurrent Paraganglioma in a Pediatric Patient with Germline Mutation.

Urol Case Rep 2017 Jul 27;13:107-109. Epub 2017 Apr 27.

National Cancer Institute, National Institutes of Health, Urologic Oncology Branch, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.eucr.2017.03.017DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5408140PMC
July 2017

Comprehensive genomic and phenotypic characterization of germline FH deletion in hereditary leiomyomatosis and renal cell carcinoma.

Genes Chromosomes Cancer 2017 06 31;56(6):484-492. Epub 2017 Mar 31.

Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/gcc.22452DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6637959PMC
June 2017

Determinants and prognostic implications of malignant ascites in metastatic papillary renal cancer.

Urol Oncol 2017 03 30;35(3):114.e9-114.e14. Epub 2016 Nov 30.

Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2016.10.023DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5318247PMC
March 2017

Accuracy and agreement of PIRADSv2 for prostate cancer mpMRI: A multireader study.

J Magn Reson Imaging 2017 02 8;45(2):579-585. Epub 2016 Jul 8.

Molecular Imaging Program, NCI, NIH, Bethesda, Maryland, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1002/jmri.25372DOI Listing
February 2017

Adrenocortical Cancer: A Molecularly Complex Disease Where Surgery Matters.

Clin Cancer Res 2016 Oct;22(20):4989-5000

James J. Peters Veterans Administration Medical Center, Bronx, New York. Division of Medical Oncology, Department of Medicine, Columbia University Medical Center, New York, New York.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1158/1078-0432.CCR-16-1570DOI Listing
October 2016

Prospective Evaluation of the Prostate Imaging Reporting and Data System Version 2 for Prostate Cancer Detection.

J Urol 2016 Sep 18;196(3):690-6. Epub 2016 Apr 18.

Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, Maryland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2016.04.057DOI Listing
September 2016

Efficiency of Prostate Cancer Diagnosis by MR/Ultrasound Fusion-Guided Biopsy vs Standard Extended-Sextant Biopsy for MR-Visible Lesions.

J Natl Cancer Inst 2016 09 29;108(9). Epub 2016 Apr 29.

Urologic Oncology Branch (MMS, AKG, RR, SRB, BJW, PAP), Molecular Imaging Program (BT, PLC), Division of Cancer Prevention (HLP), Laboratory of Pathology (MJM), and Center for Interventional Oncology, Department of Radiology and Imaging Sciences (BJW, PAP), National Cancer Institute, National Institutes of Health, Bethesda, MD; Biometric Research Branch, Division of Cancer Treatment and Diagnosis, National Cancer Institute, National Institutes of Health, Rockville, MD (RMS); Department of Surgery, Division of Urology, University of Maryland, Baltimore MD (MMS); Departments of Urology and Radiology, University of Alabama at Birmingham, Birmingham, AL (SRB)

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1093/jnci/djw039DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6059120PMC
September 2016

Midline lesions of the prostate: role of MRI/TRUS fusion biopsy and implications in Gleason risk stratification.

Int Urol Nephrol 2016 Sep 15;48(9):1445-52. Epub 2016 Jun 15.

Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, 10 Center Drive, Building 10, Room 1-5940, 20892, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s11255-016-1336-6DOI Listing
September 2016

Differentiating Transition Zone Cancers From Benign Prostatic Hyperplasia by Quantitative Multiparametric Magnetic Resonance Imaging.

J Comput Assist Tomogr 2016 Mar-Apr;40(2):218-24

From the *Molecular Imaging Program, National Cancer Institute, National Institutes of Health, Bethesda, MD; †iCAD, Inc, Nashua, NH; ‡Division of Cancer Treatment and Diagnosis, Biometric Research Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD; §Imaging Physics, SAIC Frederick, Inc, National Cancer Institute-Frederick, Frederick, MD; and ∥Laboratory of Pathology, ¶Center for Interventional Oncology, and #Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RCT.0000000000000353DOI Listing
August 2016

Multiparametric Magnetic Resonance Imaging of Recurrent Prostate Cancer.

Top Magn Reson Imaging 2016 Jun;25(3):139-47

*Molecular Imaging Program, NCI, NIH, Bethesda, MD †Department of Radiology, George Washington University Hospital, Washington, DC ‡Hacettepe University, School of Medicine, Department of Radiology, Ankara, Turkey §Laboratory of Pathology, NCI ¶Center for Interventional Oncology, NCI and Radiology and Imaging Sciences, Clinical Center ||Urologic Oncology Branch, NCI, NIH, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RMR.0000000000000088DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5462597PMC
June 2016

Papillary Renal-Cell Carcinoma.

N Engl J Med 2016 05;374(20):1991

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMc1601872DOI Listing
May 2016

Genomic characterization of sarcomatoid transformation in clear cell renal cell carcinoma.

Proc Natl Acad Sci U S A 2016 Feb 10;113(8):2170-5. Epub 2016 Feb 10.

Department of Pathology, University of California, Los Angeles School of Medicine, Los Angeles, CA 90095;

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1525735113DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4776463PMC
February 2016

Comprehensive Molecular Characterization of Papillary Renal-Cell Carcinoma.

Authors:
W Marston Linehan Paul T Spellman Christopher J Ricketts Chad J Creighton Suzanne S Fei Caleb Davis David A Wheeler Bradley A Murray Laura Schmidt Cathy D Vocke Myron Peto Abu Amar M Al Mamun Eve Shinbrot Anurag Sethi Samira Brooks W Kimryn Rathmell Angela N Brooks Katherine A Hoadley A Gordon Robertson Denise Brooks Reanne Bowlby Sara Sadeghi Hui Shen Daniel J Weisenberger Moiz Bootwalla Stephen B Baylin Peter W Laird Andrew D Cherniack Gordon Saksena Scott Haake Jun Li Han Liang Yiling Lu Gordon B Mills Rehan Akbani Mark D M Leiserson Benjamin J Raphael Pavana Anur Donald Bottaro Laurence Albiges Nandita Barnabas Toni K Choueiri Bogdan Czerniak Andrew K Godwin A Ari Hakimi Thai H Ho James Hsieh Michael Ittmann William Y Kim Bhavani Krishnan Maria J Merino Kenna R Mills Shaw Victor E Reuter Ed Reznik Carl S Shelley Brian Shuch Sabina Signoretti Ramaprasad Srinivasan Pheroze Tamboli George Thomas Satish Tickoo Kenneth Burnett Daniel Crain Johanna Gardner Kevin Lau David Mallery Scott Morris Joseph D Paulauskis Robert J Penny Candace Shelton W Troy Shelton Mark Sherman Eric Thompson Peggy Yena Melissa T Avedon Jay Bowen Julie M Gastier-Foster Mark Gerken Kristen M Leraas Tara M Lichtenberg Nilsa C Ramirez Tracie Santos Lisa Wise Erik Zmuda John A Demchok Ina Felau Carolyn M Hutter Margi Sheth Heidi J Sofia Roy Tarnuzzer Zhining Wang Liming Yang Jean C Zenklusen Jiashan Zhang Brenda Ayala Julien Baboud Sudha Chudamani Jia Liu Laxmi Lolla Rashi Naresh Todd Pihl Qiang Sun Yunhu Wan Ye Wu Adrian Ally Miruna Balasundaram Saianand Balu Rameen Beroukhim Tom Bodenheimer Christian Buhay Yaron S N Butterfield Rebecca Carlsen Scott L Carter Hsu Chao Eric Chuah Amanda Clarke Kyle R Covington Mahmoud Dahdouli Ninad Dewal Noreen Dhalla Harsha V Doddapaneni Jennifer A Drummond Stacey B Gabriel Richard A Gibbs Ranabir Guin Walker Hale Alicia Hawes D Neil Hayes Robert A Holt Alan P Hoyle Stuart R Jefferys Steven J M Jones Corbin D Jones Divya Kalra Christie Kovar Lora Lewis Jie Li Yussanne Ma Marco A Marra Michael Mayo Shaowu Meng Matthew Meyerson Piotr A Mieczkowski Richard A Moore Donna Morton Lisle E Mose Andrew J Mungall Donna Muzny Joel S Parker Charles M Perou Jeffrey Roach Jacqueline E Schein Steven E Schumacher Yan Shi Janae V Simons Payal Sipahimalani Tara Skelly Matthew G Soloway Carrie Sougnez Angela Tam Donghui Tan Nina Thiessen Umadevi Veluvolu Min Wang Matthew D Wilkerson Tina Wong Junyuan Wu Liu Xi Jane Zhou Jason Bedford Fengju Chen Yao Fu Mark Gerstein David Haussler Katayoon Kasaian Phillip Lai Shiyun Ling Amie Radenbaugh David Van Den Berg John N Weinstein Jingchun Zhu Monique Albert Iakovina Alexopoulou Jeremiah J Andersen J Todd Auman John Bartlett Sheldon Bastacky Julie Bergsten Michael L Blute Lori Boice Roni J Bollag Jeff Boyd Erik Castle Ying-Bei Chen John C Cheville Erin Curley Benjamin Davies April DeVolk Rajiv Dhir Laura Dike John Eckman Jay Engel Jodi Harr Ronald Hrebinko Mei Huang Lori Huelsenbeck-Dill Mary Iacocca Bruce Jacobs Michael Lobis Jodi K Maranchie Scott McMeekin Jerome Myers Joel Nelson Jeremy Parfitt Anil Parwani Nicholas Petrelli Brenda Rabeno Somak Roy Andrew L Salner Joel Slaton Melissa Stanton R Houston Thompson Leigh Thorne Kelinda Tucker Paul M Weinberger Cynthia Winemiller Leigh Anne Zach Rosemary Zuna

PET/CT imaging of renal cell carcinoma with (18)F-VM4-037: a phase II pilot study.

Abdom Radiol (NY) 2016 Jan;41(1):109-18

Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Building 10, Room 2 W-5940, 10 Center Drive, MSC 1210, Bethesda, MD, 20892-1210, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00261-015-0599-1DOI Listing
January 2016

Prostate Cancer: Interobserver Agreement and Accuracy with the Revised Prostate Imaging Reporting and Data System at Multiparametric MR Imaging.

Radiology 2015 Dec 18;277(3):741-50. Epub 2015 Jun 18.

From the Molecular Imaging Program (B.G.M., S.S., P.L.C., B.T.), Biometric Research Branch, Division of Cancer Treatment and Diagnosis (J.H.S.), Urologic Oncology Branch (S.R.B., A.G., P.P.), Laboratory of Pathology (M.J.M.), and Center for Interventional Oncology (B.J.W.), National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Bldg 10, Room B3B85, Bethesda, MD 20892-1088; Department of Urology, AMC University Hospital, Amsterdam, the Netherlands (B.G.M., J.J.M.C.H.d.l.R.); and Department of Radiology and Radiological Sciences, Edward Hébert School of Medicine, Uniformed Services University of The Health Sciences, Bethesda, Md (J.M.).

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1148/radiol.2015142818DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4666087PMC
December 2015

Mitochondrial DNA mutations distinguish bilateral multifocal renal oncocytomas from familial Birt-Hogg-Dubé tumors.

Mod Pathol 2015 Nov 2;28(11):1458-69. Epub 2015 Oct 2.

Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/modpathol.2015.101DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4628590PMC
November 2015

Urinary Bladder Paragangliomas: How Immunohistochemistry Can Assist to Identify Patients With SDHB Germline and Somatic Mutations.

Am J Surg Pathol 2015 Nov;39(11):1488-92

*Translational Surgical Pathology Section, Laboratory of Pathology, National Cancer Institute †Eunice Kennedy Shriver, National Institute of Child Health and Human Development ‡Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/PAS.0000000000000534DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4606469PMC
November 2015

The Role of Magnetic Resonance Image Guided Prostate Biopsy in Stratifying Men for Risk of Extracapsular Extension at Radical Prostatectomy.

J Urol 2015 Jul 23;194(1):105-111. Epub 2015 Jan 23.

Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Center for Interventional Oncology, National Cancer Institute & Clinical Center, National Institutes of Health, Bethesda, Maryland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2015.01.072DOI Listing
July 2015

A Phase I Dosing Study of Ferumoxytol for MR Lymphography at 3 T in Patients With Prostate Cancer.

AJR Am J Roentgenol 2015 Jul;205(1):64-9

1 Molecular Imaging Program, National Cancer Institute, National Institutes of Health, 10 Center Dr, MSC 1182, Bldg 10, Rm B3B85, Bethesda, MD 20892-1088.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.2214/AJR.14.13009DOI Listing
July 2015

Germline HABP2 Mutation Causing Familial Nonmedullary Thyroid Cancer.

N Engl J Med 2015 Jul;373(5):448-55

From the Endocrine Oncology Branch (S.K.G., L.Z., D.P., E.K.), Bioinformatics Core (L.J.) and Laboratory of Pathology (M.J.M.), Center for Cancer Research, and the Office of Science and Technology Resources (M.C.), National Cancer Institute, and the Metabolic Diseases Branch, National Institute of Diabetes and Digestive and Kidney Diseases (S.K.A.) - both in Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1056/NEJMoa1502449DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4562406PMC
July 2015

Use of serial multiparametric magnetic resonance imaging in the management of patients with prostate cancer on active surveillance.

Urol Oncol 2015 May 6;33(5):202.e1-202.e7. Epub 2015 Mar 6.

Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD; Center for Interventional Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.urolonc.2015.01.023DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC6663486PMC
May 2015

Upgrading prostate cancer following proton beam therapy.

Urol Ann 2015 Apr-Jun;7(2):262-4

Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA ; Center for Interventional Oncology, National Cancer Institute, National Institutes of Health, Bethesda, MD, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.4103/0974-7796.152944DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4374273PMC
April 2015

Comparison of calculated and acquired high b value diffusion-weighted imaging in prostate cancer.

Abdom Imaging 2015 Mar;40(3):578-86

Molecular Imaging Program, National Cancer Institute (NCI), NIH 10 Center Dr, MSC 1182, Bldg 10, Room B3B85, Bethesda, MD, 20892-1088, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00261-014-0246-2DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC5540661PMC
March 2015

Folliculin-interacting proteins Fnip1 and Fnip2 play critical roles in kidney tumor suppression in cooperation with Flcn.

Proc Natl Acad Sci U S A 2015 Mar 16;112(13):E1624-31. Epub 2015 Mar 16.

Urologic Oncology Branch, Center for Cancer Research, National Cancer Institute, National Institutes of Health, Bethesda, MD 20892; Basic Science Program, Leidos Biomedical Research, Inc., Frederick National Laboratory for Cancer Research, Frederick, MD 21702

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1073/pnas.1419502112DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4386336PMC
March 2015

The role of image guided biopsy targeting in patients with atypical small acinar proliferation.

J Urol 2015 Feb 20;193(2):473-478. Epub 2014 Aug 20.

Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Center for Interventional Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Clinical Center, National Institutes of Health, Bethesda, Maryland. Electronic address:

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1016/j.juro.2014.08.083DOI Listing
February 2015

Comparison of MR/ultrasound fusion-guided biopsy with ultrasound-guided biopsy for the diagnosis of prostate cancer.

JAMA 2015 Jan;313(4):390-7

Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland6Center for Interventional Oncology, Department of Radiology and Imaging Sciences, NIH Clinical Center and National Cancer Institute, National Institutes.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1001/jama.2014.17942DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4572575PMC
January 2015

Identification of threshold prostate specific antigen levels to optimize the detection of clinically significant prostate cancer by magnetic resonance imaging/ultrasound fusion guided biopsy.

J Urol 2014 Dec 9;192(6):1642-8. Epub 2014 Aug 9.

Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Center for Interventional Oncology, National Cancer Institute, National Institutes of Health, Bethesda, Maryland; Clinical Center, National Institutes of Health, Bethesda, Maryland. Electronic address:

View Article

Download full-text PDF

Source
https://linkinghub.elsevier.com/retrieve/pii/S00225347140416
Publisher Site
http://dx.doi.org/10.1016/j.juro.2014.08.002DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4684948PMC
December 2014

A phase II study of medroxyprogesterone acetate in patients with hormone receptor negative metastatic breast cancer: translational breast cancer research consortium trial 007.

Breast Cancer Res Treat 2014 Nov 26;148(1):99-106. Epub 2014 Sep 26.

Indiana University Melvin and Bren Simon Cancer Center, 535 Barnhill Drive, RT 473, Indianapolis, IN, 46202, USA,

View Article

Download full-text PDF

Source
http://link.springer.com/10.1007/s10549-014-3131-3
Publisher Site
http://dx.doi.org/10.1007/s10549-014-3131-3DOI Listing
November 2014

Multiparametric magnetic resonance imaging of the prostate aids detect lesion progression.

J Comput Assist Tomogr 2014 Jul-Aug;38(4):565-7

*From the Molecular Pharmacology Section, Medical Oncology Branch, and †Molecular Imaging Program, National Cancer Institute, Bethesda, MD; ‡Urologic Oncology Branch, NCI, NIH, Bethesda, MD; §Center for Interventional Oncology, Radiology and Imaging Sciences CC, NIH, Bethesda, MD; ∥Clinical Pharmacology Program, Center for Cancer Research, National Cancer Institute, Bethesda, MD; and ¶Laboratory of Pathology, NCI, NIH, Bethesda, MD.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1097/RCT.0000000000000069DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4101022PMC
September 2014

miR-145 suppresses thyroid cancer growth and metastasis and targets AKT3.

Endocr Relat Cancer 2014 Aug 29;21(4):517-31. Epub 2014 Apr 29.

Endocrine Oncology BranchLaboratory of PathologyNational Cancer Institute, National Institutes of Health, Center for Cancer Research, Bethesda, Maryland 20892, USA

View Article

Download full-text PDF

Source
http://erc.endocrinology-journals.org/content/early/2014/04/
Web Search
http://erc.endocrinology-journals.org/cgi/doi/10.1530/ERC-14
Publisher Site
http://dx.doi.org/10.1530/ERC-14-0077DOI Listing
August 2014

Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers.

Nat Rev Urol 2014 Aug 22;11(8):465-75. Epub 2014 Jul 22.

Urologic Oncology Branch, National Cancer Institute, National Institutes of Health, Building 10, CRC Room 1-5940, Bethesda, MD 20892, USA.

View Article

Download full-text PDF

Source
http://dx.doi.org/10.1038/nrurol.2014.162DOI Listing
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC4551450PMC
August 2014